210 related articles for article (PubMed ID: 30077147)
1. Mitoxantrone-loaded chitosan/hyaluronate polyelectrolyte nanoparticles decorated with amphiphilic PEG derivates for long-circulating effect.
Wang J; Asghar S; Jin X; Chen Z; Huang L; Ping Q; Zong L; Xiao Y
Colloids Surf B Biointerfaces; 2018 Nov; 171():468-477. PubMed ID: 30077147
[TBL] [Abstract][Full Text] [Related]
2. Chitosan hydrochloride/hyaluronic acid nanoparticles coated by mPEG as long-circulating nanocarriers for systemic delivery of mitoxantrone.
Wang J; Asghar S; Yang L; Gao S; Chen Z; Huang L; Zong L; Ping Q; Xiao Y
Int J Biol Macromol; 2018 Jul; 113():345-353. PubMed ID: 29486258
[TBL] [Abstract][Full Text] [Related]
3. Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor.
Xu Y; Asghar S; Gao S; Chen Z; Huang L; Yin L; Ping Q; Xiao Y
Int J Nanomedicine; 2017; 12():7337-7350. PubMed ID: 29066886
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells.
Yang L; Gao S; Asghar S; Liu G; Song J; Wang X; Ping Q; Zhang C; Xiao Y
Int J Biol Macromol; 2015 Jan; 72():1391-401. PubMed ID: 25450553
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol sulfate-mediated ion-pairing facilitates the self-nanoassembly of hydrophilic cationic mitoxantrone.
Zhang J; Fang H; Dai Y; Li Y; Li L; Zuo S; Liu T; Sun Y; Shi X; He Z; Sun J; Sun B
J Colloid Interface Sci; 2024 Sep; 669():731-739. PubMed ID: 38735255
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone.
Sargazi A; Kamali N; Shiri F; Heidari Majd M
Artif Cells Nanomed Biotechnol; 2018 May; 46(3):500-509. PubMed ID: 28503952
[TBL] [Abstract][Full Text] [Related]
7. Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: in vitro and in vivo investigations.
Zafar S; Negi LM; Verma AK; Kumar V; Tyagi A; Singh P; Iqbal Z; Talegaonkar S
Int J Pharm; 2014 Dec; 477(1-2):454-68. PubMed ID: 25445525
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.
Guissi NE; Li H; Xu Y; Semcheddine F; Chen M; Su Z; Ping Q
Mol Pharm; 2017 Apr; 14(4):1082-1094. PubMed ID: 28191959
[TBL] [Abstract][Full Text] [Related]
9. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
[TBL] [Abstract][Full Text] [Related]
10. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases.
Lu B; Xiong SB; Yang H; Yin XD; Chao RB
Eur J Pharm Sci; 2006 May; 28(1-2):86-95. PubMed ID: 16472996
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.
Jin Y; Wu Z; Li C; Zhou W; Shaw JP; Baguley BC; Liu J; Zhang W
Pharm Res; 2018 Jan; 35(1):13. PubMed ID: 29302821
[TBL] [Abstract][Full Text] [Related]
13. Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin.
Termsarasab U; Yoon IS; Park JH; Moon HT; Cho HJ; Kim DD
Int J Pharm; 2014 Apr; 464(1-2):127-34. PubMed ID: 24451239
[TBL] [Abstract][Full Text] [Related]
14. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
15. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
Deng L; Dong H; Dong A; Zhang J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
[TBL] [Abstract][Full Text] [Related]
16. Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate.
Abbad S; Wang C; Waddad AY; Lv H; Zhou J
Int J Nanomedicine; 2015; 10():305-20. PubMed ID: 25609946
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles.
Zhang LK; Hou SX; Zhang JQ; Hu WJ; Wang CY
Arch Pharm Res; 2010 Aug; 33(8):1193-8. PubMed ID: 20803122
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
Sargazi A; Shiri F; Keikha S; Majd MH
Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the PEG Density in the PEGylated Chitosan Nanoparticles as a Drug Carrier for Curcumin and Mitoxantrone.
Chen Y; Wu D; Zhong W; Kuang S; Luo Q; Song L; He L; Feng X; Tao X
Nanomaterials (Basel); 2018 Jul; 8(7):. PubMed ID: 29966380
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux.
Ling G; Zhang T; Zhang P; Sun J; He Z
Drug Dev Ind Pharm; 2016 Aug; 42(8):1351-9. PubMed ID: 26754913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
